% of Cases treated with Radiotherapy
| UKIACR average (population) | UKIACR average (country) | England | Scotland | Northern Ireland | Wales | |
|---|---|---|---|---|---|---|
| All invasive xnmsc | 19.3% | 19.9% | 19.4% | 17.8% | 22.5% | 19.7% |
| All xnmsc 0-24 | 15.1% | 15.4% | 15.0% | 17.8% | 14.8% | 14.0% |
| All xnmsc 25-59 | 23.7% | 25.3% | 23.4% | 24.3% | 27.6% | 25.7% |
| All xnmsc 60-79 | 21.2% | 21.6% | 21.3% | 18.7% | 25.2% | 21.2% |
| All xnmsc 80+ | 10.8% | 10.2% | 11.0% | 8.7% | 10.2% | 10.8% |
| Haematology | 9.2% | 7.7% | 9.5% | 8.8% | 4.5% | 7.9% |
| Head and Neck | 58.9% | 58.6% | 59.9% | 46.3% | 61.8% | 66.5% |
| Lower GI | 12.9% | 13.3% | 12.8% | 12.5% | 14.2% | 13.5% |
| Upper GI | 19.0% | 17.7% | 19.7% | 11.2% | 15.4% | 24.3% |
| HPB | 2.7% | 2.4% | 2.8% | 1.4% | 2.5% | 3.1% |
| Trachea, Bronchus & Lung | 25.5% | 26.1% | 25.4% | 25.9% | 29.0% | 24.3% |
| Melanoma of skin | 1.2% | 0.9% | 1.3% | 0.3% | 0.9% | 0.9% |
| Breast | 33.0% | 34.6% | 32.8% | 34.2% | 39.7% | 31.8% |
| Cervix | 42.5% | 49.0% | 41.0% | 49.2% | 58.9% | 46.9% |
| Other Female Genitals | 15.1% | 18.1% | 14.4% | 15.8% | 20.3% | 21.8% |
| Prostate | 17.7% | 16.4% | 18.8% | 6.4% | 26.4% | 14.2% |
| Kidney | 6.5% | 7.3% | 6.4% | 6.9% | 7.8% | 8.0% |
| Bladder | 18.6% | 19.0% | 18.5% | 17.6% | 18.3% | 21.7% |
| Brain and CNS | 45.3% | 45.2% | 45.2% | 45.7% | 42.3% | 47.6% |
| Thyroid & other endocrine glands | 24.6% | 23.0% | 25.2% | 17.2% | 26.3% | 23.6% |
| CUP | 9.4% | 10.5% | 9.2% | 9.4% | 14.4% | 9.1% |
| Other invasive cancer | 14.5% | 15.2% | 14.5% | 12.6% | 17.0% | 16.8% |
| Breast in situ | 26.4% | 30.3% | 25.7% | 31.9% | 43.8% | 19.7% |
| Cervix in situ | 0.0% | 0.1% | 0.0% | 0.0% | 0.3% | 0.0% |
| Other tumours | 1.0% | 0.9% | 1.1% | 0.2% | 1.5% | 0.7% |
| Non-Melanoma Skin Cancer | 1.6% | 1.3% | 1.7% | 0.7% | 1.5% | 1.4% |